M
Monopar Therapeutics Inc.
MNPR · NASDAQ · Healthcare · 757M
Closing price
$78.96
-5.98% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-38.2×
Free cash flow yieldFCF yield
-2.1%
Return on equityROE
-10.0%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
4.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.